uniQure Inc is a leading biopharmaceutical company specializing in gene therapy, with a focus on developing innovative treatments for genetic diseases such as Huntington's Disease, Hemophilia B, and Temporal Lobe Epilepsy. With locations in Lexington, MA, the USA, and Amsterdam, the Netherlands, uniQure is dedicated to pioneering advancements in gene therapy and providing hope for patients and their families.
Driven by a commitment to scientific innovation and collaboration, uniQure's pipeline of clinical trials and research programs demonstrates their dedication to improving patient outcomes and transforming the field of gene therapy. With a strong emphasis on excellence in manufacturing and operations, uniQure is at the forefront of developing cutting-edge therapies that have the potential to revolutionize the treatment of genetic diseases.
Generated from the website